The Value of Occult Disease in Resection Margin and Lymph Node After Extrapleural Pneumonectomy for Malignant Mesothelioma

Annals of Thoracic Surgery

Volumn 85, Issue 5, 2008, Pages 1740-1746

  Mineo, Tommaso Claudio ^a   Ambrogi, Vincenzo ^a   Pompeo, Eugenio ^a   Baldi, Alfonso ^b   Stella, Franco ^c   Aurea, Paolo ^c   Marino, Mario ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETININ; CISPLATIN; ETOPOSIDE; GEMCITABINE; MESOTHELIN; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LUNG RESECTION; LYMPH NODE; MALE; MALIGNANT MESOTHELIOMA; MEDIASTINOSCOPY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS OF VARIANCE; OCCULT CANCER; OCCULT DISEASE; PLEURA MESOTHELIOMA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS; UNIVARIATE ANALYSIS;

EID: 42949093528     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.01.088     Document Type: Article

References (22)

1. J. Peto A. DeCarli C. La Vecchia F. Levi E. Negri The European mesothelioma epidemic Br J Cancer 79 1999 666 672
2. R.M. Flores V.W. Rusch Diffuse malignant mesothelioma T. Shields General thoracic surgery 2005 Lippincott Williams & Wilkins Philadelphia 901 921
3. J.P.C. Steele A. Klabatsa D.A. Fennel Prognostic factors in mesothelioma Lung Cancer 49 Suppl 1 2005 S49 S52
4. D. Sugarbaker R. Flores M. Jaklitsch Resection margins, extrapleural nodal status and cell type determine postoperative long term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients J Thorac Cardiovasc Surg 117 1999 54 65
5. W. Weder P. Kestenholz C. Taverna Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma J Clinl Oncol 22 2004 3451 3457
6. V.W. Rusch E.S. Venkatraman Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically Ann Thorac Surg 68 1999 1799 1804
7. P.V. Schil Malignant pleural mesothelioma: staging systems Lung Cancer 49 Suppl 1 2005 S45 S48
8. V.W. Rusch A proposed new international TNM-staging system for malignant pleural mesothelioma: International Mesothelioma Interest Group Chest 108 1995 1122 1128
9. J.E. Pilling D.J. Stewart A.E. Martin-Ucar S. Muller K.J. O'Byrne D.A. Waller The case of routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma Eur J Cardiothorac Surg 25 2004 497 501
10. D.C. Rice J.J. Erasmus W.S. Craig Extended surgical staging for potentially resectable malignant pleural mesothelioma Ann Thorac Surg 80 2005 1988 1993
11. J.G. Edwards D.J. Stewart A. Martin-Ucar S. Muller C. Richards D.A. Waller The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma J Thorac Cardiovasc Surg 131 2006 981 987
12. M. De Perrot K. Uy M. Anraku Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma J Thorac Cardiovasc Surg 133 2007 111 116
13. T.C. Mineo V. Ambrogi E. Pompeo A. Baldi Immunohistochemistry-detected microscopic tumor spread affects outcome in en-bloc resection for T3-chest wall lung cancer Eur J Cardiothorac Surg 31 2007 1120 1124
14. N.G. Ordonez The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma Am J Surg Pathol 27 2003 1031 1051
15. D.J. Sugarbaker E.C. Heher T.H. Lee Extrapleural pneumonectomy, chemotherapy and radiotherapy in the treatment of diffuse malignant pleural mesothelioma J Thorac Surg Cardiovasc Surg 102 1991 10 15
16. D.C. Rice C.W. Stevens A.M. Correa Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma Ann Thorac Surg 84 2007 1685 1692
17. J. Edwards K. Abrams J. Leverment T. Spyt D. Waller K. O'Byrne Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems Thorax 55 2000 731 735
18. K. Prenzel S. Monig J. Sinning Lymph node size and metastatic infiltration in non-small cell lung cancer Chest 97 2003 1148 1151
19. D.B. Schneider C. Clary-Macy S. Challa Positron emission tomography with F18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma J Thorac Cardiovasc Surg 120 2000 128 133
20. R.M. Flores T. Akhurst M. Gonen Positron emission tomography predicts survival in malignant pleural mesothelioma J Thorac Cardiovasc Surg 132 2006 763 768
21. G. Maggi C. Casadio R. Cianci O. Rena E. Ruffini Trimodality management of malignant pleural mesothelioma Eur J Cardiothorac Surg 19 2001 346 350
22. J. Schouwink L. Kool E. Rutgers The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma Ann Thorac Surg 75 2003 1715 1719